BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 33418171)

  • 1. FLAIR-only joint volumetric analysis of brain lesions and atrophy in clinically isolated syndrome (CIS) suggestive of multiple sclerosis.
    Goodkin O; Prados F; Vos SB; Pemberton H; Collorone S; Hagens MHJ; Cardoso MJ; Yousry TA; Thornton JS; Sudre CH; Barkhof F;
    Neuroimage Clin; 2021; 29():102542. PubMed ID: 33418171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.
    Meier DS; Guttmann CRG; Tummala S; Moscufo N; Cavallari M; Tauhid S; Bakshi R; Weiner HL
    J Neuroimaging; 2018 Jan; 28(1):36-47. PubMed ID: 29235194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis.
    Akaishi T; Takahashi T; Fujihara K; Misu T; Mugikura S; Abe M; Ishii T; Aoki M; Nakashima I
    PLoS One; 2020; 15(4):e0231225. PubMed ID: 32243459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects.
    Tran P; Thoprakarn U; Gourieux E; Dos Santos CL; Cavedo E; Guizard N; Cotton F; Krolak-Salmon P; Delmaire C; Heidelberg D; Pyatigorskaya N; Ströer S; Dormont D; Martini JB; Chupin M;
    Neuroimage Clin; 2022; 33():102940. PubMed ID: 35051744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are multi-contrast magnetic resonance images necessary for segmenting multiple sclerosis brains? A large cohort study based on deep learning.
    Narayana PA; Coronado I; Sujit SJ; Sun X; Wolinsky JS; Gabr RE
    Magn Reson Imaging; 2020 Jan; 65():8-14. PubMed ID: 31670238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
    Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.
    Valverde S; Oliver A; Roura E; Pareto D; Vilanova JC; Ramió-Torrentà L; Sastre-Garriga J; Montalban X; Rovira À; Lladó X
    Neuroimage Clin; 2015; 9():640-7. PubMed ID: 26740917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of portable low-field magnetic resonance imaging for multiple sclerosis lesions.
    Arnold TC; Tu D; Okar SV; Nair G; By S; Kawatra KD; Robert-Fitzgerald TE; Desiderio LM; Schindler MK; Shinohara RT; Reich DS; Stein JM
    Neuroimage Clin; 2022; 35():103101. PubMed ID: 35792417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Cortical and Deep Gray Matter Lesions in Multiple Sclerosis Using DIR and FLAIR at 3T.
    Park CC; Thongkham DW; Sadigh G; Saindane AM; Chu R; Bakshi R; Allen JW; Hu R
    J Neuroimaging; 2021 Mar; 31(2):408-414. PubMed ID: 33351983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
    Biberacher V; Schmidt P; Keshavan A; Boucard CC; Righart R; Sämann P; Preibisch C; Fröbel D; Aly L; Hemmer B; Zimmer C; Henry RG; Mühlau M
    Neuroimage; 2016 Nov; 142():188-197. PubMed ID: 27431758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images.
    Jain S; Sima DM; Ribbens A; Cambron M; Maertens A; Van Hecke W; De Mey J; Barkhof F; Steenwijk MD; Daams M; Maes F; Van Huffel S; Vrenken H; Smeets D
    Neuroimage Clin; 2015; 8():367-75. PubMed ID: 26106562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
    Lie IA; Kerklingh E; Wesnes K; van Nederpelt DR; Brouwer I; Torkildsen Ø; Myhr KM; Barkhof F; Bø L; Vrenken H
    Eur Radiol; 2022 May; 32(5):3576-3587. PubMed ID: 34978580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis.
    Guo C; Ferreira D; Fink K; Westman E; Granberg T
    Eur Radiol; 2019 Mar; 29(3):1355-1364. PubMed ID: 30242503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
    Chu R; Hurwitz S; Tauhid S; Bakshi R
    BMC Neurol; 2017 Sep; 17(1):172. PubMed ID: 28874119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®.
    Cavedo E; Tran P; Thoprakarn U; Martini JB; Movschin A; Delmaire C; Gariel F; Heidelberg D; Pyatigorskaya N; Ströer S; Krolak-Salmon P; Cotton F; Dos Santos CL; Dormont D
    Eur Radiol; 2022 May; 32(5):2949-2961. PubMed ID: 34973104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimizing the effect of white matter lesions on deep learning based tissue segmentation for brain volumetry.
    Clèrigues A; Valverde S; Salvi J; Oliver A; Lladó X
    Comput Med Imaging Graph; 2023 Jan; 103():102157. PubMed ID: 36535217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic Review.
    Lie IA; Weeda MM; Mattiesing RM; Mol MAE; Pouwels PJW; Barkhof F; Torkildsen Ø; Bø L; Myhr KM; Vrenken H
    Neurology; 2022 Apr; 98(15):e1562-e1573. PubMed ID: 35173016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis.
    Schmidt P; Gaser C; Arsic M; Buck D; Förschler A; Berthele A; Hoshi M; Ilg R; Schmid VJ; Zimmer C; Hemmer B; Mühlau M
    Neuroimage; 2012 Feb; 59(4):3774-83. PubMed ID: 22119648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of MRI T1 Hypointense Brain Lesions on Cerebral Deep Gray Matter Volume Measures in Multiple Sclerosis.
    Buyukturkoglu K; Mormina E; De Jager PL; Riley CS; Leavitt VM
    J Neuroimaging; 2019 Jul; 29(4):458-462. PubMed ID: 30892794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
    Popescu V; Ran NC; Barkhof F; Chard DT; Wheeler-Kingshott CA; Vrenken H
    Neuroimage Clin; 2014; 4():366-73. PubMed ID: 24567908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.